Tumor-associated macrophage-induced circMRCKα encodes a peptide to promote glycolysis and progression in hepatocellular carcinoma
Cancer Letters · 2024-06 · 591 · 216872
DOI: 10.1016/j.canlet.2024.216872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2024-06. Verfasst von Songyang Yu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China; Department of…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Glycolysis, Liver Neoplasms, RNA, Circular. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Ministry of Science and Technology, National Natural Science Foundation of China.
Abstract (Originalsprache)
The tumor-associated macrophages (TAMs) play multifaceted roles in the progression of hepatocellular carcinoma (HCC). However, the involvement of circular RNAs in the interplay between TAMs and HCC remains unclear. Based on Transwell co-culturing and circular RNA sequencing, this study revealed that TAMs enhanced tumor glycolysis and progression by upregulating circMRCKα in HCC cells. Patients with HCC who exhibited elevated circMRCKα levels presented significantly reduced overall survival and greater cumulative recurrence. Notably, we identified a novel functional peptide of 227 amino acids named circMRCKα-227aa, encoded by circMRCKα. Mechanistically, circMRCKα-227aa bound to USP22 and enhanced its protein level to obstruct HIF-1α degradation via the ubiquitin-proteasome pathway, thereby augmenting HCC glycolysis and progression. In clinical HCC samples, a positive correlation was observed between the expression of circMRCKα and the number of infiltrating CD68+ TAMs and expression of USP22. Furthermore, circMRCKα emerged as an independent prognostic risk factor both individually and in conjunction with CD68+ TAMs and USP22. This study illustrated that circMRCKα-227aa, a novel TAM-induced peptide, promotes tumor glycolysis and progression via USP22 binding and HIF-1α upregulation, suggesting that circMRCKα and TAMs could be combined as therapeutic targets in HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China; Department of Colorectal Surgery, The First Affiliated Hospital, Zhejiang Universit…
- Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry o…
Förderung
- China Postdoctoral Science Foundation
- Ministry of Science and Technology
- National Natural Science Foundation of China
- National Major Science and Technology Projects of China
Zitieren
APA
Yu, S., Su, S., Wang, P., Li, J., Chen, C., Xin, H., Gong, Y., Wang, H., Ye, X., Mao, L., Zhou, Z., Zhou, S., Hu, Z., & Huang, X. (2024). Tumor-associated macrophage-induced circMRCKα encodes a peptide to promote glycolysis and progression in hepatocellular carcinoma. Cancer Letters, 591, 216872. https://doi.org/10.1016/j.canlet.2024.216872
Vancouver
Yu S, Su S, Wang P, Li J, Chen C, Xin H, et al. Tumor-associated macrophage-induced circMRCKα encodes a peptide to promote glycolysis and progression in hepatocellular carcinoma. Cancer Letters. 2024;591:216872. doi:10.1016/j.canlet.2024.216872
BibTeX
@article{Yu2024,
author = {Yu, Songyang and Su, Sheng and Wang, Pengcheng and Li, Jia and Chen, Changzhou and Xin, Haoyang and Gong, Yu and Wang, Hezhi and Ye, Xinming and Mao, Li and Zhou, Zhengjun and Zhou, Shaolai and Hu, Zhiqiang and Huang, Xiaowu},
title = {Tumor-associated macrophage-induced circMRCKα encodes a peptide to promote glycolysis and progression in hepatocellular carcinoma},
journal = {Cancer Letters},
year = {2024},
volume = {591},
pages = {216872},
doi = {10.1016/j.canlet.2024.216872}
}
EUVIMED